Research in brief

ABSTRACT

The authors reported no adverse reactions to phage therapy, regardless of type of bacterial infection, type of phages used, or method of treatment. 11 patients displayed some measure of symptom improvement or reduced bacterial presence;four exhibited no response to treatment. T-helper cells key to malaria vaccine Scientists studying why immunity against Plasmodium falciparum lasts only a short time after immunisation found that T-helper cells reacted exclusively to the protein sequence of the vaccine strain and showed hardly any cross-reactivity with naturally occurring variants. For more on cancer drug and SARS-CoV-2 see ACS Infect Dis 2022;published online June 29. https//doi.org/10.1021/acsinfecdis.2c00008 For more on COVID-19 in pregnancy in sub-Saharan Africa see Clin Infect Dis 2022;published online June 8. https//doi.org/10.1093/cid/ciac294 For more on the spread of enteric viruses through saliva see Nature 2022;published online June 29. https//doi.org/10.1038/s41586-022-04895-8 For more on influenza vaccination and Alzheimer's disease see J Alzheimers Dis 2022;published online June 13. https//doi.org/10.3233/jad-220361 For more on extensively drug-resistant Neisseria gonorrhoeae see Euro Surveill 2022;27 2200455 For more on bacteriophage therapy case series see Clin Infect Dis 2022;published online June 9. https//doi.org/10.1093/cid/ciac453 For more on T-helper cells and malaria vaccine see Sci Immunol 2022;7 eabm9644